MEK in cancer and cancer therapy-Reference-Cited by-同舟云学术

MEK in cancer and cancer therapy

Published:2014-02 Issue:2 Volume:141 Page:160-171
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Neuzillet Cindy,Tijeras-Raballand Annemilaï,de Mestier Louis,Cros Jérôme,Faivre Sandrine,Raymond Eric

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference130 articles.

1. Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3;Abel;J Clin Invest,2013

2. Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK;Allan;Nat Cell Biol,2003

3. Identification of unique MEK-dependent genes in GNAQ mutant uveal melanoma involved in cell growth, tumor cell invasion, and MEK resistance;Ambrosini;Clin Cancer Res,2012

4. MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study;Ascierto;Lancet Oncol,2013

5. Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)–MAPK cell survival signals;Ballif;Cell Growth Differ,2001

Cited by 204 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ginsenoside CK ameliorates tumor growth in lung cancer mice via inhibiting EGFR;Journal of Functional Foods;2024-10

2. Targeting the RAS upstream and downstream signaling pathway for cancer treatment;European Journal of Pharmacology;2024-09

3. Early growth response factor 1 promotes HCC progression by activating the MAPK/ERK pathway through transcriptional upregulation of PAR1;2024-08-16

4. Stratifin-mediated activation of AKT signaling and therapeutic targetability in hepatocellular carcinoma progression;Cell Insight;2024-08

5. Integrative analysis of metabolomics and proteomics reveals mechanism of berberrubine-induced nephrotoxicity;Toxicology and Applied Pharmacology;2024-07